Outcomes of patients experiencing cardiovascular adverse events within 1 year following craniotomy for intracranial aneurysm clipping: a retrospective cohort study.
10.12122/j.issn.1673-4254.2022.07.20
- Author:
Na CHEN
1
;
Ren Hua LI
2
;
E WANG
1
;
De Hua HU
3
;
Zhao Hui TANG
1
Author Information
1. Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha 410008, China.
2. Department of Anesthesiology, Hunan Provincial People's Hospital, Changsha 410005, China.
3. School of Life Sciences, Central South University, Changsha 410008, China.
- Publication Type:Journal Article
- Keywords:
cardiovascular adverse events;
craniotomy;
intracranial aneurysm;
mortality;
prognosis
- MeSH:
Craniotomy/adverse effects*;
Humans;
Intracranial Aneurysm/surgery*;
Postoperative Period;
Retrospective Studies;
Subarachnoid Hemorrhage/surgery*;
Treatment Outcome
- From:
Journal of Southern Medical University
2022;42(7):1095-1099
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the impact of postoperative serious cardiovascular adverse events (CAE) on outcomes of patients undergoing craniotomy for intracranial aneurysm clipping.
METHODS:This retrospective cohort study was conducted among the patients undergoing craniotomy for intracranial aneurysm clipping during the period from December, 2016 to December, 2017, who were divided into CAE group and non-CAE group according to the occurrence of Clavien-Dindo grade ≥II CAEs after the surgery. The perioperative clinical characteristics of the patients, complications and neurological functions during hospitalization, and mortality and neurological functions at 1 year postoperatively were evaluated. The primary outcome was mortality within 1 year after the surgery. The secondary outcomes were Glasgow outcome scale (GOS) score at 1 year, lengths of postoperative hospital and intensive care unit (ICU) stay, and Glasgow coma scale (GCS) score at discharge.
RESULTS:A total of 361 patients were enrolled in the final analysis, including 20 (5.5%) patients in CAE group and 341 in the non-CAE group. No significant differences were found in the patients' demographic characteristics, clinical history, or other postoperative adverse events between the two groups. The 1-year mortality was significantly higher in CAE group than in the non-CAE group (20.0% vs 5.6%, P=0.01). Logistics regression analysis showed that when adjusted for age, gender, emergency hospitalization, subarachnoid hemorrhage, volume of bleeding, duration of operation, aneurysm location, and preoperative history of cardiovascular disease, postoperative CAEs of Clavien-Dindo grade≥II was independently correlated with 1-year mortality rate of the patients with an adjusted odds ratio of 3.670 (95% CI: 1.037-12.992, P=0.04). The patients with CEA also had a lower GOS score at 1 year after surgery than those without CEA (P=0.002). No significant differences were found in the occurrence of other adverse events, postoperative hospital stay, ICU stay, or GCS scores at discharge between the two groups (P > 0.05).
CONCLUSION:Postoperative CAEs may be a risk factor for increased 1-year mortality and disability in patients undergoing craniotomy for intracranial aneurysms.
